Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:22 p.m.

    📋 MODERNA, INC. (MRNA) - Financial Results

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 07:04:18

    Event Type: Financial Results

    Event Details:

    Moderna Inc (MRNA) Reports Q3 2022 Financial Results Moderna Inc (MRNA) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 2506
    • Net Income: 5854
    • EPS: $5.24
    • Cash and equivalents: 2885
      • expected in 4Q 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 121.00 479.00 $-358.00 -74.74%
    Operating Expenses Interest Income 3.00 55.00 $-52.00 -94.55%
    Current Assets Prepaid Expenses Other Current Assets 1.05K 728.00 $326.00 +44.78%
    Current Assets Property Equipment Net 1.32K 1.24K $83.00 +6.69%
    Current Liabilities Accounts Payable 181.00 181.00 $0.00 +0.00%
    Current Liabilities Accrued Liabilities 1.78K 1.47K $308.00 +20.92%
    Changes In Assets And Liabilities Prepaid Expenses Other Current Assets -324.00 -110.00 $-214.00 -194.55%
    Changes In Assets And Liabilities Accounts Payable -56.00 44.00 $-100.00 -227.27%
    Changes In Assets And Liabilities Accrued Liabilities 305.00 367.00 $-62.00 -16.89%
    Changes In Assets And Liabilities Operating Lease Liabilities -19.00 8.00 $-27.00 -337.50%
    Revenue 183.00 183.00 $0.00 +0.00%
    Selling, General & Administrative 211.00 211.00 $0.00 +0.00%
    Interest Income 40.00 40.00 $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 1.05K 728.00 $326.00 +44.78%
    Property and Equipment, Net 1.32K 1.24K $83.00 +6.69%
    Accounts Payable 181.00 181.00 $0.00 +0.00%
    Accrued Liabilities 1.78K 1.47K $308.00 +20.92%
    Operating Lease Liabilities 87.00 106.00 $-19.00 -17.92%
    Other Assets -324.00 -110.00 $-214.00 -194.55%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Moderna Inc
    • CIK: 0001682852
    • Ticker Symbol: MRNA
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories